December 1, 2017
Destiny Pharma, China’s CMS Medical Venture ink deal for dealing with Destiny’s drug candidates in Asian region
Destiny Pharma said on Friday that its development and commercialisation collaboration agreement with CMS Medical Venture Investment Limited, a wholly…